ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $2,405,000 | -46.2% | 59,505 | -23.5% | 0.12% | -44.3% |
Q2 2015 | $4,474,000 | +141.4% | 77,735 | +167.1% | 0.22% | +140.7% |
Q1 2015 | $1,853,000 | -40.1% | 29,098 | -63.4% | 0.09% | -51.9% |
Q3 2014 | $3,091,000 | +30.4% | 79,594 | +15.7% | 0.19% | +33.1% |
Q2 2014 | $2,370,000 | – | 68,795 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |